A worldwide clinical trial aimed at finding treatments for Alzheimer’s disease has expanded to include investigational drugs targeting a harmful…
Read More
Phase 3 trial of Novavax investigational COVID-19 vaccine opens
The Phase 3 trial of another investigational coronavirus disease 2019 (COVID-19) vaccine has begun enrolling adult volunteers. The randomized, placebo-controlled…
Read More
Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectiveness
TUESDAY, Oct. 27, 2020 — Testing of the Eli Lilly antibody drug for hospitalized COVID-19 patients has been halted because…
Read More
Major COVID-19 vaccine trial resumes in UK after safety review
Pharma giant AstraZeneca and Oxford University on Saturday said they had resumed a COVID-19 vaccine trial after getting the all-clear…
Read More
South Africa rolls out second coronavirus vaccine trial
South Africa will launch clinical trials of a US-developed coronavirus vaccine with 2,900 volunteers this week, the second such study…
Read More
Closely watched arthritis drug disappoints in COVID-19 trial
An arthritis drug that was being closely watched for its potential use against COVID-19 has delivered disappointing results in clinical…
Read More
Canadian clinical trial tests plasma therapy for COVID-19
Can those who survive COVID-19 provide blood to treat others hospitalized by the disease? That’s the question driving a Canadian…
Read More
First human trial of monoclonal antibody to prevent malaria opens
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling…
Read More
Trial suggests babies in intensive care can be better protected from parental bacteria
For sick or prematurely born babies spending their first days of life in a hospital’s neonatal intensive care unit (NICU),…
Read More
First-in-human trial for new lung cancer immunotherapy
Cancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine…
Read More